Showing results (551-560 of 3,170) with videos related to

Sort By:
Pageof 317
Translational Oncology|June 21, 2018
Molecular Characterization and Putative Pathogenic Pathways of Tuberous Sclerosis Complex-Associated Renal Cell CarcinomaJeong Hwan Park, Cheol Lee, Mee Soo Chang, et al.
Translational Oncology|June 12, 2018
Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, et al.
Translational Oncology|June 9, 2018
Relationship of In Vivo MR Parameters to Histopathological and Molecular Characteristics of Newly Diagnosed, Nonenhancing Lower-Grade GliomasTracy L Luks, Tracy Richmond McKnight, Llewellyn E Jalbert, et al.
Translational Oncology|June 11, 2014
Molecular imaging of oral premalignant and malignant lesions using fluorescently labeled lectinsJohn Baeten, Amritha Suresh, Alexander Johnson, et al.
Translational Oncology|June 11, 2014
PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer CellsKumar Sanjiv, Chi-Wei Chen, Rajesh Kakadiya, et al.
Translational Oncology|June 11, 2014
Clinical Relevance of Increased Endothelial and Mesothelial Expression of Proangiogenic Proteases and VEGFA in the Omentum of Patients with Metastatic Ovarian High-Grade Serous CarcinomaBoleslaw K Winiarski, Nichola Cope, Mary Alexander, et al.
Translational Oncology|May 20, 2014
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888Richard Tuli, Andrew J Surmak, Juvenal Reyes, et al.
Translational Oncology|May 20, 2014
A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer1,2.Shuang Zhao, S Laura Chang, Jennifer J Linderman, et al.
Translational Oncology|April 30, 2023
Metastatic breast tumors downregulate miR-145 regulating the hypoxia-induced vasculogenic mimicryEstefania Contreras-Sanzón, Ángeles Carlos-Reyes, Mónica Sierra-Martínez, et al.
Translational Oncology|May 24, 2023
Bicistronic CAR-T cells targeting CD123 and CLL1 for AML to reduce the risk of antigen escapeDanni Xie, Xin Jin, Rui Sun, et al.
Pageof 317